the Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxaliplatin
NCT05494320
·
clinicaltrials.gov ↗
UNKNOWN
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Gastrointestinal Cancer
Interventions
DRUG:
Folfox Protocol
Sponsor
Ain Shams University